Lysophosphatidic acid, a growth factor-like lipid, in the saliva

Journal of Lipid Research

Volumn 43, Issue 12, 2002, Pages 2049-2055

  Sugiura, Takayuki ^a   Nakane, Shinji ^a,c   Kishimoto, Seishi ^a   Waku, Keizo ^a   Yoshioka, Yasuko ^b   Tokumura, Akira ^b  

^a TEIKYO UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c GUNMA UNIVERSITY   (Japan)

Author keywords

Carcinoma; Esophagus; Growth factor; Lysophosphatidic acid; Molecular species; Mouth; Pharynx; Saliva; Tissue injury

Indexed keywords

CALCIUM; CELL RECEPTOR; FATTY ACID; GROWTH FACTOR; LYSOPHOSPHATIDIC ACID; MESSENGER RNA; PHOSPHOLIPID; CELL SURFACE RECEPTOR; G PROTEIN COUPLED RECEPTOR; LYSOPHOSPHATIDIC ACID RECEPTOR; LYSOPHOSPHOLIPID;

ARTICLE; CALCIUM CELL LEVEL; CELL GROWTH; CONCENTRATION (PARAMETERS); ESOPHAGUS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LYSOPLASMANIC ACID; MOUTH CARCINOMA; PHARYNX; PRIORITY JOURNAL; SALIVA; TISSUE INJURY; WOUND HEALING; BIOSYNTHESIS; CELL CULTURE; CHEMISTRY; EPITHELIUM; GENETICS; GROWTH, DEVELOPMENT AND AGING; MASS SPECTROMETRY; METABOLISM;

CALCIUM; EPITHELIUM; ESOPHAGUS; HUMANS; LYSOPHOSPHOLIPIDS; MASS SPECTROMETRY; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, LYSOPHOSPHATIDIC ACID; RNA, MESSENGER; SALIVA; TUMOR CELLS, CULTURED;

EID: 0036906499     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M200242-JLR200     Document Type: Article

References (49)

1. Tokumura, A., K. Fukuzawa, and H. Tsukatani, 1978. Effects of synthetic and natural lysophosphatidic acids on the arterial blood pressure of diffirent animal species. Lipids. 13: 572-574.
2. Tokumura, A., K. Fukuzawa, and H. Tsukatani. 1982. Contractile actions of lysophosphatidic acids with a chemically-defined fatty acyl group on longitudinal muscle from guinea-pig ileum. J. Pharm. Pharmacol. 34: 514-516.
3. Schumacher, K. A. H. G. Classen, and M. Spath. 1979. Platelet aggregation evoked in vitro and in vivo by phosphatidic acids and lysoderivatives: Identity with substances in aged serum (DAS). Thromb. Haemost. 42: 631-640.
4. Gerrard, J. M., S. E. Kindom, D. A. Peterson, J. Peller, K. E. Krantz, and J. G. White. 1979. Lysophosphatidic acid. Influence on platelet aggregation and intracellular calcium flux. Am. J. Pathol. 96: 423-438.
5. Tokumura, A., K. Fukuzawa, J. Isobe, and H. Tsukatani. 1981. Lysophosphatidic acid-induced aggregation of human and feline platelets: Structure-activity relationship. Biochem. Biophys. Res. Commun. 99: 391-398.
6. van Corven, E.J., A. Groenink, K. Jalink, T. Eichholtz, and W. H. Moolenaar. 1989. Lysophosphatidate-induced cell proliferation: Identification and dissection of signaling pathways mediated by G proteins. Cell. 59: 45-54.
7. Tokumura, A., M. Iimori, Y. Nishioka, M. Kitahara, M. Sakashita, and S. Tanaka. 1994. Lysophosphatidic acids induce proliferation of cultured vascular smooth muscle cells from rat aorta. Am. J. Physiol. 267: C204-210.
8. Balazs, L., J. Okolicany, M. Ferrebee, B. Tolley, and G. Tigyi. 2001. Topical application of the phospholipid growth factor lysophosphatidic acid promotes wound healing in vivo. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280: R466-472.
9. Tigyi, G., and R. Miledi. 1992. Lysophosphatidates bound to serum albumin activate membrane currents in Xenopus oocytes and neurite retraction in PC 12 pheochromocytoma cells. J. Biol. Chem. 267: 21360-21367.
10. Jalink, K., T. Eichholtz, F. R. Postma, E.J. van Corven, and W. H. Moolenaar. 1993. Lysophosphatidic acid induces neuronal shape changes via a novel, receptor-mediated signaling pathway: Similarity to thrombin action. Cell Growth Differ 4: 247-255.
11. Levine, J. S., J. S. Koh, V. Triaca, and W. Lieberthal. 1997. Lysophosphatidic acid: A novel growth and survival factor for renal proximal tubular cells. Am. J. Physiol. 273: F575-585.
12. Weiner, J. A., and J. Chun. 1999. Schwann cell survival mediated by the signaling phospholipid lysophosphatidic acid. Proc. Natl. Acad. Sci. USA. 96: 5233-5238.
13. Koh, J. S., W. Lieberthal, S. Heydrick, and J. S. Levine. 1998. Lysophosphatidic acid is a major serum noncytokine survival factor for murine macrophages which acts via the phosphatidylinositol 3-kinase signaling pathway. J. Clin. Invest. 102: 716-727.
14. Kobayashi, T., S. Yamano, S. Murayama, H. Ishikawa, A. Tokumura, and T. Aono. 1994. Effect of lysophosphatidic acid on the preimplantation development of mouse embryos. FEBS Lett. 351: 38-40.
15. Kunikata, K., S. Yamano, A. Tokumura, and T. Aono. 1999. Effect of lysophosphatidic acid on the ovum transport in mouse oviducts. Life Sci. 65: 833-840.
16. Schulze, C., C. Smales, L. L. Rubin, and J. M. Staddon. 1997. Lysophosphatidic acid increases tight junction permeability in cultured brain endothelial cells. J. Neurochem. 68: 991-1000.
17. Zhou, D., W. Luini, S. Bernasconi, L. Diomede, M. Salmona, A. Mantovani, and S. Sozzani. 1995. Phosphatidic acid and lysophosphatidic acid induce haptotactic migration of human monocytes. J. Biol. Chem. 270: 25549-25556.
18. Imamura, F., T. Horai, M. Mukai, K. Shinki, M. Sawada, and H. Akedo. 1993. Induction of in vitro tumor cell invasion of cellular monolayers by lysophasphatidic acid or phospholipase D. Biochem. Biophys. Res. Commun. 193: 497-503.
19. Simon, M. F., H. Chap, and L. Douste-Blazy. 1982. Human platelet aggregation induced by 1-alkyl-lyasophosphatidic acid and its analogs: A new group of phospholipid mediators? Biochem. Biophys. Res. Commun. 108: 1743-1750.
20. Tokumura, A., J. Yoshida, T. Maruyama, K. Fukuzawa, and H. Tsukatani. 1987. Platelet aggregation induced by ether-linked phospholipids. I. Inhibitory actions bovine serum albumin and structural analogues of platelet activating factor. Thromb. Res. 46: 51-63.
21. Sugiura, T., A. Tokumura, L. Gregory, T. Nouchi, S. T. Weintraub, and D. J. Hanahan. 1994. Biochemical characterization of the interaction of lipid phosphoric acids with human platelets: Comparison with platelet-activating factor. Arch. Biochem. Biophys. 311: 358-368.
22. Sugiura, T., S. Nakane, S. Kishimoto, K. Waku, Y., Yoshioka, A. Tokumura, and D. J. Hanahan. 1999. Occurrence of lysophosphatidic acid and its alkyl ether-linked analog in rat brain and comparison of their biological activities toward cultured neural cells. Biochim. Biophys. Acta. 1440: 194-204.
23. Jalink, K., P. Hordijk, and W. H. Moolenaar. 1994. Growth factor-like effects of lysophosphatidic acid, a novel lipid meditator. Biochim. Biophys. Acta. 1198: 185-196.
24. Moolenaar, W. H. 1995. Lysophosphatidic acid, a multifunctional phospholipid messenger. J. Biol. Chem. 270:12949-12952.
25. Tokumura, A. 1995. A family of phospholipid autacoids: Occurrence, metabolism and bioactions. Prog. Lipid Res. 34: 151-184.
26. Durieux, M. E. 1995. Lysophosphatidate Signaling: Cellular Effect and Molecular Mechanisms. Spring-Verlag, Heidelberg.
27. Goetzl, E. J., and S. An. 1998. Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine 1-phosphate. FASEB J. 12: 1589-1598.
28. Tigyi, G. J., K. Liliom, D. Fischer, and Z. Guo. 1998. Phospholipid growth factors: Identification and mechanism of action. In Lipid Second Messengers. R.P. Rubin and S. Laychock, editors. CRC Press, Boca Raton, FL. 51-81.
29. Contos, J.J., I. Ishii, and J. Chun. 2000. Lysophosphatidic acid receptors. Mol. Pharmacol. 58: 1188-1196.
30. Hecht, J. H., J. A. Weiner, S. R. Post, and J. Chun. 1996. Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex. J. Cell Biol. 135: 1071-1083.
31. An, S., M. A. Dickens, T. Bleu, O. G. Hallmark, and E. J. Goetzl. 1997. Molecular cloning of the human Edg2 protein and its identification as a functional cellular receptor for lysophosphatidic acid. Biochem. Biophys. Res. Commun. 231: 619-622.
32. An, S., T. Bleu, O. G. Hallmark, and E. J. Goetzl. 1998. Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid. J. Biol. Chem. 273: 7906-7910.
33. Bandoh, K., J. Aoki, H. Hosono, S. Kobayashi, T. Kobayashi, K. Murakami-Murofushi, M. Tsujimoto, H. Arai, and K. Inoue. 1999. Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid. J. Biol. Chem. 274: 27776-27785.
34. Nakane, S., T. Tokumura, K. Waku, and T. Sugiura. 2001. Hen egg yolk and white contain high amounts of lysophosphatidic acids, growth factor-like lipids: Distinct molecular species compositions. Lipids. 36: 413-419.
35. Das, A. K., and A. K. Hajra. 1989. Quantification, characterization and fatty acid composition of lysophosphatidic acid in different rat tissues. Lipids. 24: 329-333.
36. Tokumura, A., K. Harada, K. Fukuzawa, and H. Tsukatani. 1986. Involvement of lysophospholipase D in the production of lysophosphatidic acid in rat plasma. Biochim. Biophys. Acta. 875:31-38.
37. Tokumura, A., H. Fujimoto, O. Yoshimoto, Y. Nishioka, M. Miyake, and K. Fukuzawa. 1999. Production of lysophosphatidic acid by lysophospholipase D in incubated plasma of spontaneously hypertensive rats and Wistar Kyoto rats. Life Sci. 65: 245-253.
38. Baker, D. I., E. S. Umstot, D. M. Desiderio, and G.J. Tigyi. 2000. Quantitative analysis of lysophosphatidic acid in human blood fractions. Ann. N. Y. Acad. Sci. 905: 267-269.
39. Baker, D. L., D. M. Desiderio, D. D. Miller, B. Tolley, and G. Y. Tigyi. 2001. Direct quantitative analysis of lysophosphatidic acid molecular species by stahle isotope dilution electrospray ionization liquid chromatography-mass spectrometry. Anal. Biochem. 292: 287-295.
40. Eichholts, T., K. Jalink, I. Fahrenfort, and W. H. Moolenaar. 1993. The bioactive phospholipid lysophosphatidic acid is released from activated platelets. Biochem. J. 291: 677-680.
41. Tokumura, A., M. Miyake, Y. Nishioka, S. Yamano, T. Aono, and K. Fukuzawa. 1999. Production of lysophosphatidic acids by lysophospholipase D in human follicular fluids of in vitro fertilization patients. Biol. Reprod. 61: 195-199.
42. Bandoh, K., J. Aoki, A. Taira, M. Tsujimoto, H. Arai, and K. Inoue. 2000. Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species. Structure-activity relationship of cloned LPA receptors. FEBS Lett. 478: 159-165.
43. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37: 911-917.
44. Tokumura, A., K. Harada, Y. Yoshioka, H. Tsukatani, and Y. Handa. 1984. Analyses of lysophosphatidic acids by gas chromatography mass spectrometry without hydrolytic pretreatment. Biomed. Mass Spectrom. 11: 167-171.
45. Xu, Y., D. C. Gaudette, J. D. Boynton, A. Frankel, X. J. Fang, A. Sharma, J. Hurteau, G. Casey, A. Goodbody, A. Mellors, B. J. Holub, and G. Mills. 1995. Characterization of an ovarian cancer activating factor in ascitcs from ovarian cancer patients. Clin. Cancer Res. 1: 1223-1232.
46. van Corven, E. J., A. van Rijswijk, K. Jalink, R. L. van der Bend, W. J. van Blitterswijk, and W. H. Moolenaar. 1992. Mitogenic action of Lysophosphatidic acid and phosphatidic acid on fibroblasts. Dependence on acyl-chain length and inhibition by suramin. Biochem. J. 281: 163-169.
47. Murphy, R. A., N. J. Pantazis, and M. Papastavros. 1979. Epidermal growth factor and nerve growth factor in mouse saliva: A comparative study. Dev. Biol. 71: 356-370.
48. Hutson, J. M., M. Niall, D. Evans, and R. Fowler. 1979. Effect of salivary glands on wound contraction in mice. Nature. 279: 793-795.
49. Li, A. K., M. J. Koroly, M. E. Schattenkerk, R. A. Malt, and M. Young. 1980. Nerve growth factor: Acceleration of the rate of wound healing in mice. Proc. Natl. Acad. Sci. USA. 77: 4379-4381.